BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|January 1, 2004
- Volume 0 0
Women Are Shortchanged on Getting Shut-Eye
Advertisement
Articles in this issue
almost 23 years ago
GER Is Common Among Children with Bronchial Asthmaalmost 23 years ago
Not All GERD Patients Are Alikealmost 23 years ago
Chronic Constipation Makes Headlinesalmost 23 years ago
Dyspepsia and Gastric Emptying in Diabeticsalmost 23 years ago
New Indications: 2003almost 23 years ago
Can You Read These Rxs? Answersalmost 23 years ago
Compounding Hotlinealmost 23 years ago
Sleep Apnea Is Tied to Depression?almost 23 years ago
RLS Runs in the Familyalmost 23 years ago
Case Studies AnswersAdvertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
2
Statin Myths: Why Patients Avoid Cholesterol-Lowering Therapy
3
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
4
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
5